Corporate Giving Program: Health Equity in Cardiovascular Disease Grant

The Corporate Giving Program by Cytokinetics focuses on health equity in cardiovascular disease, targeting underserved communities. It seeks to fund initiatives that address disparities in healthcare access, including public health campaigns, community support programs, and innovative solutions. Eligible organizations must be 501(c)(3) nonprofits in the U.S. that align with these goals, ensuring that no direct healthcare practice involvement occurs. This initiative aims to foster equitable health outcomes and enhance community well-being.

Cytokinetics: Health Equity in Cardiovascular Disease
Equitable healthcare initiatives for cardiovascular disease (CVD) in underserved communities with the aim to help reduce disparities. Initiatives may include public health and/or awareness programs; non-healthcare community support programs; community-led solutions; access to basic services; new innovative approaches
Location focus: U.S.-based national initiative or community-based program

Eligibility

Cytokinetics provides charitable donations to qualified 501(c)(3) organizations in the U.S. that are neither engaged, nor directly involved in the practice of healthcare, and whose missions and programs are aligned with our corporate giving priorities. Eligible organizations must meet the funding and eligibility criteria set out by Cytokinetics. No benefit may be given to Cytokinetics in return for support unless such benefit is incidental in nature, such as fair recognition of company name on a list of donors.

Ineligibility

Cytokinetics does not fund activities that have already occurred.